Profile Picture
Français
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Canada
  • World
  • Entertainment
  • Sci/Tech
  • Business
  • Politics
  • Sports
  • Lifestyle
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Alzheimer's, Novo Nordisk

Digest more
 · 20h · on MSN
Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says
An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, drugmaker Novo Nordisk said Monday.

Continue reading

 · 1d · on MSN
Novo Nordisk Stock Plummets After Ozempic-Maker’s Alzheimer’s Drug Trial Fails
 · 23h · on MSN
Novo Nordisk’s Ozempic Pill Fails in Long-Shot Alzheimer’s Effort
2h

What's Happening With Novo Nordisk Stock?

While Eli Lilly stock has surged beyond a $1 trillion market capitalization, Novo Nordisk is having difficulty keeping up, both in growth and pipeline progression.
22hon MSN

Novo Nordisk Faces Setback. Here's What Caused the Ozempic Maker's Stock to Tumble Monday.

Novo Nordisk shares tumbled Monday morning after the Danish drugmaker posted the latest results from a drug trial.
7don MSN

Novo Nordisk to offer select doses of Ozempic, Wegovy at a steep discount

Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
  • Privacy
  • Terms